(Q36674762)

15 August 2017

1 reference

title

Terlipressin: vasopressin analog and novel drug for septic shock (English)

1 reference

15 August 2017

0 references

0 references

1 reference

Adam B Pesaturo

1

1 reference

15 August 2017

Heath R Jennings

series ordinal

2

1 reference

15 August 2017

Stacy A Voils

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

5 December 2006

1 reference

Annals of Pharmacotherapy

15 August 2017

published in

1 reference

15 August 2017

volume

40

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

2170-2177

1 reference

Cardiovascular management of septic shock

15 August 2017

cites work

1 reference

The pathogenesis of vasodilatory shock

21 January 2018

1 reference

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

21 January 2018

1 reference

Modification of alpha1 -adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis

21 January 2018

1 reference

Vasopressin and terlipressin: pharmacology and its clinical relevance

21 January 2018

1 reference

Circulating vasopressin levels in septic shock.

21 January 2018

1 reference

Physiology of vasopressin relevant to management of septic shock

21 January 2018

1 reference

Beneficial effects of short-term vasopressin infusion during severe septic shock

21 January 2018

1 reference

Vasopressin in hypotensive and shock states

21 January 2018

1 reference

Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.

21 January 2018

1 reference

Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial

21 January 2018

1 reference

Conversion of triglycylvasopressin to lysine-vasopressin in man.

21 January 2018

1 reference

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series

21 January 2018

1 reference

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study

21 January 2018

1 reference

Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep

21 January 2018

1 reference

Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport

21 January 2018

1 reference

Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats

21 January 2018

1 reference

Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism

21 January 2018

1 reference

Terlipressin for norepinephrine-resistant septic shock

21 January 2018

1 reference

Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock

21 January 2018

1 reference

Terlipressin in catecholamine-resistant septic shock patients

21 January 2018

1 reference

Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?

21 January 2018

1 reference

Terlipressin-exacerbated hypokalaemia

21 January 2018

1 reference

Terlipressin in patients with septic shock: friend or foe?

21 January 2018

1 reference

Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis

21 January 2018

1 reference

Low-dose terlipressin for hemodynamic support in sepsis and systemic inflammatory response syndrome: art for (he)art's sake or state of the art?

21 January 2018

1 reference

Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1H373

1 reference

15 August 2017

1 reference